Established in 2003, this manufacturer specializes in developing, manufacturing, and marketing a diverse portfolio of pharmaceutical products. As a CTD dossier owner and manufacturer, it holds WHO-GMP certification and complies with various international regulatory standards, including EFDA Ethiopia, PPB Kenya, FDA Philippines, NAFDAC Nigeria, DPM Ivory Coast, MOH Cambodia, and NMHPRA Afghanistan. The manufacturer operates two state-of-the-art WHO-GMP manufacturing units producing general category formulations such as tablets, oral liquids, capsules, and sachets. A new facility under its sister concern, operational since May, is compliant with USFDA, PIC/S, and UKMHRA guidelines. As a CTD dossier owner and manufacturer, its products are distributed across multiple countries worldwide.

The CTD dossier owner and manufacturer is a leading conglomerate with a diverse range of business operations across multiple industries. The website is structured to provide detailed financial information through sections like “Annual Report,” “Quarterly Report,” and “Price Sensitive Information,” which include links to various reports from recent years and updates on financial performance, such as notices about bond issuances. The company operates in several key sectors, including textiles, pharmaceuticals, personal protective equipment (PPE), ceramics, information and communication technology (ICT), real estate and trading, media, financial services, energy, and travel and tourism. As the largest entity within its group, the company plays a significant role in driving economic activities and growth across these industries, reflecting its strong market presence and commitment to diversified business interests.

This CTD dossier owner and manufacturer, based in the Middle East, boasts over two decades of experience in the industry. They produce a wide range of pharmaceuticals, including both prescription and over-the-counter medications, as well as food supplements. Their focus areas include central nervous system, gynecology, and cardiovascular health, with a growing presence in the vitamin and supplement markets. The company manufactures products in various dosage forms, including solids, injectables, and liquids, and adheres to strict EU and USA GMP standards. They prioritize expanding into new markets and have a track record of achieving notable success in the region. While specific product patents are not mentioned on the website, their commitment to quality and innovation is evident in their wide range of products and dedicated manufacturing facilities.